6533b82afe1ef96bd128cc14
RESEARCH PRODUCT
Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Martin GrabenwögerFernando AlfonsoJean BachetRobert BonserMartin CzernyHolger EggebrechtArturo EvangelistaRossella FattoriHeinz JakobLars LönnChristoph A NienaberGuido RocchiHervè RousseauMatt ThompsonErnst WeigangRaimund Erbel European Association For Cardio-thoracic Surgery (Eacts) European Society Of Cardiology (Esc) European Association Of Percutaneous Cardiovascular Interventionsubject
Aortic archEndoleakMedizinAnastomotic LeakAorta ThoracicChest painPatient Care PlanningAortic aneurysmPostoperative ComplicationsIntraoperative ComplicationsBrain DiseasesEndovascular ProceduresAngiographyEquipment DesignGeneral MedicineTreatment OutcomeCardiothoracic surgeryDescending aortacardiovascular systemCardiologyStentsmedicine.symptomCardiology and Cardiovascular MedicinePulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusAortic DiseasesPerioperative CareSpinal Cord DiseasesBlood Vessel Prosthesis ImplantationAneurysmBlood vessel prosthesismedicine.arteryInternal medicineMonitoring IntraoperativemedicineHumansAortaAortic Aneurysm Thoracicbusiness.industryContraindicationsPatient SelectionVascular System Injuriesmedicine.diseaseSurgeryBlood Vessel ProsthesisAortic DissectionSurgerybusinessTomography X-Ray ComputedEchocardiography Transesophagealdescription
Thoracic endovascular aortic repair (TEVAR) is an emerging treatment modality, which has been rapidly embraced by clinicians treating thoracic aortic disease.1–4 Fundamentally, it is a far less invasive approach than open surgery and its availability and relative ease of application has changed and extended management options in thoracic aortic disease, including in those patients deemed unfit or unsuitable for open surgery. In the operating room, this requires considerable perceptual, cognitive and psychomotor demands on the operators. The dramatic expansion of TEVAR activity has necessarily prompted a requirement to systematically consider the indications, appropriateness, limitations and delivery of this treatment, which has been adopted by many specialties including cardiologists, cardiovascular surgeons, radiologists and vascular surgeons.5 Our task has been to generate a multidisciplinary position statement that supports and advises all clinicians utilizing this technological advance. This document focuses on the main diagnoses—thoracic aortic aneurysm (TAA), thoracic aortic dissection (TAD) of the descending aorta (type B according to the Stanford classification) and thoracic aortic injury (TAI)—indications and applicability of TEVAR and includes information regarding its limitations and complications. It acts as a position statement for both societies that reflects current understanding of thoracic aortic endovascular therapy. ### Evaluation of symptoms and patient status Symptoms in patients with TAA and chronic dissection are rare and non-specific.6,7 New onset of hoarseness or dysphagia may suggest a developing aneurysm in the distal aortic arch and proximal descending aorta. Most asymptomatic cases are discovered incidentally, while symptomatic patients have usually developed complications. Even in patients with acute aortic syndromes, chest pain, back pain and signs of malperfusion are often misinterpreted due to lack of awareness. In cases of clinical suspicion, a computed tomography (CT)-angiography is the diagnostic modality of first choice. ### Multidisciplinary consultation Patient selection should be performed on an individual basis according to anatomy, pathology, comorbidity and …
year | journal | country | edition | language |
---|---|---|---|---|
2012-05-08 | European Journal of Cardio-Thoracic Surgery |